Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.

Milone, Maria Rita

Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype. [electronic resource] - Oncotarget Mar 2015 - 5324-41 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.2694 doi


Blotting, Western
Bone Density Conservation Agents--pharmacology
Cell Movement
Cell Proliferation
Diphosphonates--pharmacology
Drug Resistance, Neoplasm
Electrophoresis, Gel, Two-Dimensional
Gene Ontology
Gene Regulatory Networks
Humans
Imidazoles--pharmacology
Male
Neoplasm Invasiveness
Prostatic Neoplasms--drug therapy
Proteomics--methods
RNA, Messenger--genetics
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction--drug effects
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tumor Cells, Cultured
Zoledronic Acid